These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27633824)
21. Association between antiphospholipid antibodies and factor Bb in lupus nephritis patients with glomerular microthrombosis. Zhou Y; Chen P; Li Y Int J Rheum Dis; 2019 Dec; 22(12):2185-2190. PubMed ID: 31749332 [TBL] [Abstract][Full Text] [Related]
22. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
25. Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies. von Scheven E; Elder ME Lupus; 2005; 14(6):440-4. PubMed ID: 16038107 [TBL] [Abstract][Full Text] [Related]
26. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158 [TBL] [Abstract][Full Text] [Related]
28. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Ostertag MV; Liu X; Henderson V; Pierangeli SS Lupus; 2006; 15(6):358-65. PubMed ID: 16830882 [TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid Syndrome and the Kidney. Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550 [TBL] [Abstract][Full Text] [Related]
31. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701 [TBL] [Abstract][Full Text] [Related]
32. Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome. Gushiken FC; Arnett FC; Ahn C; Thiagarajan P Arthritis Rheum; 1999 Jun; 42(6):1189-93. PubMed ID: 10366111 [TBL] [Abstract][Full Text] [Related]
33. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome. Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885 [TBL] [Abstract][Full Text] [Related]
34. Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome? Renaud M; Aupy J; Uring-Lambert B; Chanson JB; Collongues N; Blanc F; De Sèze J Eur J Neurol; 2014 Jun; 21(6):901-6. PubMed ID: 24698178 [TBL] [Abstract][Full Text] [Related]
35. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478 [TBL] [Abstract][Full Text] [Related]
37. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Xie H; Sheng L; Zhou H; Yan J Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619 [TBL] [Abstract][Full Text] [Related]
38. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134 [TBL] [Abstract][Full Text] [Related]
39. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome]. Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Kushnir VV; Shakhnova EA; Miroshnichenko NG; Serova AG; Nesterova SG Ter Arkh; 2007; 79(6):16-25. PubMed ID: 17684961 [TBL] [Abstract][Full Text] [Related]
40. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome. Matsuura E; Kobayashi K; Hurley BL; Lopez LR Lupus; 2006; 15(7):478-83. PubMed ID: 16898186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]